Related Experiment Video

Updated: Sep 27, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Lipids as a target for drugs modulating multidrug resistance of cancer cells

A B Hendrich1, K Michalak

  • 1Department of Biophysics, Wroclaw Medical University, Chalubinskiego 10, Wroclaw 50 368, Poland. hendrich@biofiz.am.wroc.pl

Current Drug Targets
|January 17, 2003
PubMed

Insights

Membrane lipids play a crucial role in multidrug resistance (MDR) by altering cell membrane properties and influencing drug transport. Understanding these lipid alterations can help develop new strategies to overcome MDR in cancer therapy.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Multidrug resistance (MDR) is a major challenge in cancer chemotherapy.
  • Alterations in cancer cell membrane lipid composition significantly impact cellular biophysical properties.
  • Lipid rafts and caveolae, enriched in sphingolipids, contribute to membrane heterogeneity and MDR.

Purpose of the Study:

  • To review the role of membrane lipids in MDR.
  • To discuss how lipid composition changes affect membrane properties in cancer cells.
  • To explore the influence of MDR modulators on membrane lipid biophysics.

Main Methods:

  • Literature review focusing on recent research findings.
  • Analysis of the relationship between lipid composition and membrane biophysical properties.
  • Discussion of the vacuum cleaner hypothesis for drug transport proteins.

Main Results:

  • Changes in lipid composition alter membrane fluidity and affect integral protein activity.
  • Membrane heterogeneity, including lipid rafts, is crucial for MDR.
  • Lipid bilayer acts as a diffusion medium for drugs, influencing influx and efflux balance.
  • MDR modulators like verapamil and tamoxifen affect membrane lipid biophysical properties.

Conclusions:

  • Membrane lipids are key players in MDR, influencing drug transport and cellular resistance.
  • Targeting membrane lipid composition and biophysical properties offers potential therapeutic strategies.
  • Modulators of MDR can exert their effects by altering membrane lipid states.

More Related Videos

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...